Piper Sandler Initiates Coverage On Korro Bio with Overweight Rating, Announces Price Target of $180
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Yasmeen Rahimi has initiated coverage on Korro Bio (NASDAQ:KRRO) with an Overweight rating and a price target of $180.
November 10, 2023 | 11:24 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler has initiated coverage on Korro Bio with an Overweight rating and a price target of $180.
The Overweight rating from Piper Sandler indicates a positive outlook for Korro Bio. The high price target of $180 suggests that the analyst sees significant upside potential in the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100